<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37118973</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Depression and anxiety in systemic lupus erythematosus: A case-control study on prevalence and associated factors in a single-center cohort.</ArticleTitle><Pagination><StartPage>827</StartPage><EndPage>832</EndPage><MedlinePgn>827-832</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231173510</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the prevalence of self-perceived depression and anxiety in patients with systemic lupus erythematosus (SLE) and to explore associated factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cross-sectional study of unselected patients with SLE (ACR-97 criteria) and controls with chronic inflammatory rheumatic diseases. Both completed the Hospital Anxiety and Depression Scale (HADS). Demographic and clinical characteristics, comorbidity, and treatments were collected, and a multivariate analysis was performed to explore factors associated with depression and anxiety in SLE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study population comprised 172 patients and 215 controls. Women accounted for 93% of the patients with SLE. Fibromyalgia was recorded in 12.8% and a history of depression in 17%. According to HADS, 37.2% fulfilled the diagnostic criteria for depression and 58.7% those for anxiety; prevalence was similar in the controls (32.6% and 55.1%, respectively). Up to a third of patients with self-perceived depression were not receiving antidepressants. There was no concordance between a previous history of depression and current depression. In the multivariate model, current depression was associated with single marital status (OR 2.69; 95% CI: 1.17-6.42; <i>p</i> = .022), fibromyalgia (7.69; 2.35-30.72; <i>p</i> = .001), smoking (3.12; 1.24-8.07; <i>p</i> = .016), severity of SLE (0.76; 0.6-0.94; <i>p</i> = .016), and organ damage (1.27; 1.01-1.61; <i>p</i> = .042). Current anxiety was only associated with fibromyalgia (3.97; 1.21-17.98; <i>p</i> = .036).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Depression and anxiety are most likely underdiagnosed in SLE. Prevalence appears to be similar to that of other chronic inflammatory rheumatic diseases. Anxiety is associated with fibromyalgia, while depression is also associated with single marital status, smoking, organ damage, and severity of SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Le&#xf3;n-Su&#xe1;rez</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8896-0393</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xfa;a-Figueroa</LastName><ForeName>I&#xf1;igo</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-7894-1690</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez Mart&#xed;n</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Statistical. Research Unit, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Sosa</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erausquin</LastName><ForeName>Celia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almeida Santiago</LastName><ForeName>Cristina Del Pino</ForeName><Initials>CDP</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubi&#xf1;o Ju&#xe1;rez</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez Vera</LastName><ForeName>Yanira</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C&#xe1;ceres Mart&#xed;n</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez S&#xe1;nchez</LastName><ForeName>Rub&#xe9;n</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quevedo Abeledo</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francisco Hern&#xe1;ndez</LastName><ForeName>F&#xe9;lix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojeda Bruno</LastName><ForeName>Soledad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naranjo Hern&#xe1;ndez</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quevedo Rodr&#xed;guez</LastName><ForeName>Adri&#xe1;n</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez Lozano</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Hospital Universitario Gran Canaria Dr Negr&#xed;n, Las Palmas de Gran Canaria, Spain.</Affiliation><Identifier Source="RINGGOLD">16461</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005356" MajorTopicYN="Y">Fibromyalgia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">depression</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>29</Day><Hour>19</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>29</Day><Hour>3</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37118973</ArticleId><ArticleId IdType="doi">10.1177/09612033231173510</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>